Condition: Respiratory Distress Syndrome (Neonatal) · Intubation Complication · Death; Neonatal · Sponsor: ONY
The purpose of this clinical study is to determine the effectiveness and safety of Infasurf® administered through the InfasurfAero™, a novel oral airway delivery device specifically designed to give Infasurf in a less complicated way and without the need for a breathing tube or interrupting nasal respiratory support.
This description comes directly from the study's public registry record.
Corey Commaroto, RRT · 7163614659 · ccommaroto@onybiotech.com
Dan Swartz, PhD · 716428-3132 · dswartz@onybiotech.com
Always discuss trial participation with your own doctor first.
| St. Josephs Hospital and Medical Center | Phoenix, Arizona, United States | Recruiting |
| Phoenix Children's | Phoenix, Arizona, United States | Recruiting |
| Sharp Mary Birch Hospital for Women & Newborns | San Diego, California, United States | Recruiting |
| University of Florida -Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Kapi'olani Medical Center for Women & Children | Honolulu, Hawaii, United States | Recruiting |
| Jersey Shore University Medical Center | Neptune City, New Jersey, United States | Recruiting |
| Sisters of Charity Hospital | Buffalo, New York, United States | Recruiting |
| Western TN- Jackson-Madison County General Hospital | Jackson, Tennessee, United States | Recruiting |
| Utah Valley Hospital | Provo, Utah, United States | Recruiting |
| Unity Point Meriter | Madison, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05960929